NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

CompletedN/A

Sponsor: Sanguine Biosciences

Conditions: Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease, Huntington's Disease, Amyotrophic Lateral Sclerosis (ALS)

Countries: United States

The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.

Eligibility overview

Sex: ALL

Age: 18 Years to 100 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Males and females \>18 to 100 years old
* A diagnosis of neurological condition
* Proof of diagnosis can be provided

Control group: Healthy donors, males and females, 18 to 100 years of age

Exclusion Criteria

* Receipt of blood products within 30 days of study enrollment
* Receipt of an investigational (unapproved) drug within 30 days of study enrollment

Locations (1)

Sherman Oaks, California, United States